Both in Biotechnology
Bio-Techne vs Kymera Therapeutics
Over the past year TECH returned +16.1% and KYMR returned +104.8%; their daily moves had a correlation of 0.12.
TECH +16.1% KYMR +104.8%Growth of $1, one year, split-adjusted
| Metric | TECH | KYMR |
|---|---|---|
| Price | $72.66 | $126.63 |
| Market cap | $11.41B | $10.81B |
| Today | −0.07% | +3.29% |
| 1 month | +0.4% | +15.0% |
| 6 months | +32.1% | +56.9% |
| Year to date | +23.6% | +62.7% |
| 1 year | +17.2% | +110.9% |
| Revenue growth (YoY) | +1.3% | −100.0% |
| Gross margin | 65.8% | — |
| Net margin | 17.0% | — |
| P/E (TTM) | 62.7× | — |
| Price / sales | 9.4× | 105.7× |
| Net cash | $64.7M | $969.2M |
| Dividend yield | 0.44% | — |
| Volatility (60d) | 2.5% | 38.9% |
| Short % of float | 4.9% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).